Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia
- PMID: 25706
Item in Clipboard
Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia
Can J Neurol Sci.
1978 Feb.
Abstract
Friedreich's ataxia is almost always associated with a cardiomyopathy. The cardiomyopathy and its attendant cardiopulmonary sequelae is the usual cause of death in this disease. The author reviews the known pharmacology of the heart, particularly as it applies to hypertrophic cardiomyopathy. The important role played by calcium and the possible role of taurine is stressed. Therapeutic possibilities are mentioned.
Similar articles
-
Cardiomyopathy in Friedreich's ataxia.Acta Neurol Belg. 2011 Sep;111(3):183-7. Acta Neurol Belg. 2011. PMID: 22141280 Review.
-
Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.Ann Neurol. 2003 Jan;53(1):121-3. doi: 10.1002/ana.10419. Ann Neurol. 2003. PMID: 12509856
-
[Cardiomyopathy in Friedreich's ataxia].Dtsch Med Wochenschr. 1992 Mar 13;117(11):432-6. doi: 10.1055/s-2008-1062330. Dtsch Med Wochenschr. 1992. PMID: 1544346 Review. German. No abstract available.
-
[Two case studies of hypertrophic cardiomyopathy in Friedreich's ataxia].Gac Med Mex. 2009 Jul-Aug;145(4):343-6. Gac Med Mex. 2009. PMID: 20073435 Spanish.
-
Friedreich's ataxia cardiomyopathy: case based discussion and management issues.Ir Med J. 2010 Apr;103(4):117-8. Ir Med J. 2010. PMID: 20486316
Cited by
-
Echocardiographic evaluation of verapamil in Friedreich's ataxia.Br Heart J. 1986 Apr;55(4):400-4. doi: 10.1136/hrt.55.4.400. Br Heart J. 1986. PMID: 3964508 Free PMC article.